Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 701–800 of 1,011
Role of the Cytoskeleton in Formation and Maintenance of Angiogenic Sprouts
Bayless, K. J., & Johnson, G. A. (2011) · Journal of Vascular Research · doi:10.1159/000324751 · Cited by 121
Liu, Z., Liu, S., Wang, F., Liu, S., & Chen, X. S. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1112-2 · Cited by 121
Zhou, Q., Sherwin, R. P., Parrish, C., Richters, V., Groshen, S. G., Tsao-Wei, D. D., & Markland, F. S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006457903545 · Cited by 121
Liu, Z., Yan, Y., Chin, F. T., Wang, F., & Chen, X. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801285t · Cited by 121
Integrins as signaling molecules and targets for tumor therapy
Ruoslahti, E. (1997) · Kidney International · doi:10.1038/ki.1997.193 · Cited by 120
Markham, T., Mullan, R. H., Golden‐Mason, L., Rogers, S. C. F., Bresnihan, B., FitzGerald, O., Fearon, U., & Veale, D. J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.038 · Cited by 120
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
Sheikh, A., Md, S., & Kesharwani, P. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.028 · Cited by 120
Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor
Kumar, C. C., Nie, H., Rogers, C. P., Malkowski, M., Maxwell, E., Catino, J. J., & Armstrong, L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37071-5 · Cited by 120
The role of integrins in the malignant phenotype of gliomas
Uhm, J. (1999) · Frontiers in Bioscience · doi:10.2741/uhm · Cited by 120
Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase.
Zagzag, D., Shif, B., Jallo, G. I., GRECO, M. A., Blanco, C., Cohen, H. W., Hukin, J., Allen, J. C., & Friedlander, D. R. (2002) · PubMed · Cited by 119
Scappaticci, F. A., Smith, R., Pathak, A., Schloss, D. J., Lum, B. L., Cao, Y., Johnson, F. L., Engleman, E. G., & Nolan, G. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0243 · Cited by 119
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
Gerlag, D. M., Borges, E., Tak, P. P., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., Ruoslahti, E. I., & Firestein, G. S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar327 · Cited by 119
Shi, J., Wang, L., Kim, Y., Zhai, S., Liu, Z., Chen, X. S., & Liu, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801134k · Cited by 119
van der Horst, G., van den Hoogen, C., Buijs, J. T., Cheung, H., Bloys, H., Pelger, R. C. M., Lorenzon, G., Heckmann, B., Feyen, J. H. M., Pujuguet, P., et al. (2011) · Neoplasia · doi:10.1593/neo.11122 · Cited by 118
Hypothesis: Thalidomide embryopathy?proposed mechanism of action
Stephens, T. D., & Fillmore, B. J. (2000) · Teratology · doi:10.1002/(sici)1096-9926(200003)61:3<189::aid-tera6>3.0.co;2-w · Cited by 118
Trusolino, L., Serini, G., Cecchini, G., Besati, C., Ambesi‐Impiombato, F. S., Marchisio, P. C., & Filippi, R. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.4.1145 · Cited by 118
Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe
Li, C., Wang, W., Wu, Q., Shi, K., Houston, J. P., Sevick-Muraca, E. M., Dong, L., Chow, D. S., Charnsangavej, C., & Gelovani, J. G. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.01.001 · Cited by 118
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
RANDI, A. M., Laffan, M., & Starke, R. D. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.060 · Cited by 118
Re: Gene Therapy Strategies for Tumor Antiangiogenesis
Stenram, U. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.1017-a · Cited by 118
Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis
Shirure, V. S., Lezia, A., Tao, A., Alonzo, L. F., & George, S. C. (2017) · Angiogenesis · doi:10.1007/s10456-017-9559-4 · Cited by 117
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line, B. R., Mitra, A., Nan, A., & Ghandehari, H. (2005) · PubMed · Cited by 117
Tyrosine kinase signal specificity: lessons from the HGF receptor
Bertotti, A., & Comoglio, P. M. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.001 · Cited by 117
Cell adhesion molecules in angiogenesis
Brooks, P. C. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437471 · Cited by 116
Self-citationHorst, A. K., Ito, W. D., Dabelstein, J., Schumacher, U., Sander, H., Turbide, C., Brümmer, J., Meinertz, T., Beauchemin, N., & Wagener, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24340 · Cited by 116
Immunological aspects of endometriosis
Vinatier, D. (1996) · Human Reproduction Update · doi:10.1093/humupd/2.5.371 · Cited by 116
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
Hagedorn, M., & Bikfalvi, A. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00056-1 · Cited by 116
Tumor Angiogenesis: Insights and Innovations
Nussenbaum, F., & Herman, I. M. (2010) · Journal of Oncology · doi:10.1155/2010/132641 · Cited by 116
Near-Infrared Fluorescence Imaging of Tumor Integrin αvβ3 Expression with Cy7-Labeled RGD Multimers
Wu, Y., Cai, W., & Chen, X. S. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0041-8 · Cited by 116
In vitro and in vivo effects of PDGF-BB delivery strategies on tendon healing: a review
Evrova, O., & Buschmann, J. (2017) · European Cells and Materials · doi:10.22203/ecm.v034a02 · Cited by 116
Biology of angiogenesis in tumors of the gastrointestinal tract
Reinmuth, N., Parikh, A. A., Ahmad, S. A., Liu, W., Stoeltzing, O., Fan, F., Takeda, A., Akagi, M., & Ellis, L. M. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10258 · Cited by 115
What have snakes taught us about integrins?
Huang, T. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050181 · Cited by 115
ANGIOGENESIS and ANGIOGENIC MEDIATORS IN HAEMATOLOGICAL MALIGNANCIES
Mangi, M. H., & Newland, A. C. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02104.x · Cited by 115
Effect of ADAM28 on Carcinoma Cell Metastasis by Cleavage of von Willebrand Factor
Mochizuki, S., Soejima, K., Shimoda, M., Abe, H., Sasaki, A., Okano, H. J., Okano, H., & Okada, Y. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs232 · Cited by 115
Ramos, O. H. P., Kauskot, A., Cominetti, M. R., Bechyne, I., Pontes, C. L. S., Chareyre, F., Manent, J., Vassy, R., Giovannini, M., Legrand, C., et al. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9101-y · Cited by 115
Cell Adhesion Molecules: Potential Therapeutic & Diagnostic Implications
Mousa, S. A. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0072-7 · Cited by 115
Crisp, J. L., Savariar, E. N., Glasgow, H. L., Ellies, L. G., Whitney, M. A., & Tsien, R. Y. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1067 · Cited by 115
Akt1 Signaling Regulates Integrin Activation, Matrix Recognition, and Fibronectin Assembly
Somanath, P. R., Kandel, E., Hay, N., & Byzova, T. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700241200 · Cited by 114
New trends in guided nanotherapies for digestive cancers: A systematic review
Fernandes, E., Ferreira, J. A., Peixoto, A., Luís, L., Barroso, S., Sarmento, B. F. C. C., & Santos, L. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.003 · Cited by 114
Delbaldo, C., Raymond, É., Vera, K., Hammershaimb, L., Kaucic, K., Lozahic, S., Marty, M. E., & Faivre, S. J. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9077-0 · Cited by 114
The role of integrins in tumor angiogenesis
Hwang, R. F., & Varner, J. A. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.09.010 · Cited by 114
αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future
Demircioglu, F., & Hodivala‐Dilke, K. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.07.008 · Cited by 114
Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade
Dietrich-Ntoukas, T., Onderka, J., Bock, F., Kruse, F. E., Vossmeyer, D., Stragies, R., Zahn, G., & Cursiefen, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060896 · Cited by 114
A stimulus-responsive contrast agent for ultrasound molecular imaging
Borden, M. A., Zhang, H., Gillies, R. J., Dayton, P. A., & Ferrara, K. W. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.011 · Cited by 114
Santoso, S., Wihadmadyatami, H., Bakchoul, T., Werth, S., Al‐Fakhri, N., Bein, G., KIEFEL, V., Zhu, J., Newman, P. J., Bayat, B., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307281 · Cited by 114
Touny, L. H. E., & Banerjee, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2958 · Cited by 113
Jiao, Y., Feng, X., Zhan, Y., Wang, R., Zheng, S., Liu, W., & Zeng, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041591 · Cited by 113
Takano, S., Tsuboi, K., Tomono, Y., Nose, T., & Mitsui, Y. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1150 · Cited by 113
Davis, G. E., & Bayless, K. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800175 · Cited by 113
Molecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 112
Impact of the protein corona on nanomaterial immune response and targeting ability
Digiacomo, L., Pozzi, D., Palchetti, S., Zingoni, A., & Caracciolo, G. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1615 · Cited by 112
Mai, J., Sameni, M., Mikkelsen, T., & Sloane, B. F. (2002) · Biological Chemistry · doi:10.1515/bc.2002.159 · Cited by 112
Tran, T. D., Caruthers, S. D., Hughes, M. S., Marsh, J. N., Cyrus, T., Winter, P. M., Neubauer, A. M., Wickline, S. A., & Lanza, G. M. (2007) · PubMed Central · Cited by 112
Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram
Shian, S.-G., Kao, Y.-R., Wu, F. Y.-H., & Wu, C. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1076 · Cited by 111
van der Schaft, D. W. J., Dings, R. P. M., de Lussanet, Q. G., van Eijk, L. I., Nap, A. W., Beets‐Tan, R. G. H., Steege, J. C. A. B.-T., Wagstaff, J., Mayo, K. H., & Griffioen, A. W. (2002) · The FASEB Journal · doi:10.1096/fj.02-0509fje · Cited by 111
Integrin αvβ3-Mediated Activation of Apoptosis
Brassard, D. L., Maxwell, E., Malkowski, M. G., Nagabhushan, T. L., Kumar, C. C., & Armstrong, L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4559 · Cited by 111
Liu, X., Wang, X., Horii, A., Wang, X., Qiao, L., Zhang, S., & Cui, F.-Z. (2012) · Nanoscale · doi:10.1039/c2nr00001f · Cited by 111
Vascular expression of the αvβ3-integrin in lung and other organs
Singh, B., Fu, C., & Bhattacharya, J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.1.l217 · Cited by 111
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
Wong, P., Muñoz‐Félix, J. M., Hijazi, M., Kim, H.-J., Robinson, S. D., de Luxán‐Delgado, B., Rodríguez‐Hernández, I., Maiques, Ó., Meng, Y.-M., Meng, Q., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.003 · Cited by 111
Luo, L., Lin, T., Yao, C., Kuo, P.-Y., Matsusaki, M., Harroun, S. G., Huang, C.-C., & Lai, J. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.041 · Cited by 111
p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration
Zhang, H., Li, Z., Viklund, E.-K., & Strömblad, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200207008 · Cited by 111
Robinson, S. D., Reynolds, L. E., Kostourou, V., Reynolds, A. R., da Silva, R. G., Tavora, B., Baker, M., Marshall, J. F., & Hodivala‐Dilke, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030700 · Cited by 111
The role of homeobox genes in vascular remodeling and angiogenesis
Gorski, D. H., & Walsh, K. (2000) · Circulation Research · doi:10.1161/01.res.87.10.865 · Cited by 110
Integrins as a distinct subtype of dependence receptors
Stupack, D. G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401658 · Cited by 110
Orecchia, A., Lacal, P. M., Schietroma, C., Morea, V., Zambruno, G., & Failla, C. M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00673 · Cited by 110
Quantitative Angiogenesis Assays in vivo – A Review
Hasan, J., Shnyder, S. D., Bibby, M., Double, J. A., Bicknel, R., & Jayson, G. C. (2004) · Angiogenesis · doi:10.1023/b:agen.0000037338.51851.d1 · Cited by 110
Xiong, X.-B., Mahmud, A., Uludaǧ, H., & Lavasanifar, A. (2007) · Biomacromolecules · doi:10.1021/bm060967g · Cited by 110
Brakebusch, C., Hirsch, E., Potocnik, A., & Fässler, R. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.23.2895 · Cited by 109
Matrix Remodeling after Stroke: De Novo Expression of Matrix Proteins and Integrin Receptors
ELLISON, J. A., BARONE, F. C., & FEUERSTEIN, G. Z. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07996.x · Cited by 109
Schwartz, E. A., Bizios, R., Medow, M. S., & Gerritsen, M. E. (1999) · Circulation Research · doi:10.1161/01.res.84.3.315 · Cited by 109
Constitutive and regulated expression of vitronectin.
Seiffert, D. (1997) · PubMed · Cited by 109
Haubner, R., & Kessler, I. H. (1997) · Angewandte Chemie · doi:10.1002/ange.19971091304 · Cited by 109
Angiogenesis and non-small cell lung cancer
Cox, G., Jones, J. L., Walker, R. A., Steward, W. P., & O'Byrne, K. J. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00096-3 · Cited by 109
Angiogenesis in rheumatoid arthritis
Zoltán, S. (2005) · Frontiers in bioscience · doi:10.2741/1657 · Cited by 108
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
Arosio, D., Manzoni, L., Araldi, E. M. V., & Scolastico, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100448r · Cited by 108
Bevilacqua, P., Barbareschi, M., Verderio, P., Boracchi, P., Caffo, O., Palma, P., Meli, S., Weidner, N., & Gasparini, G. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666041 · Cited by 108
Wang, C., Mäkilä, E. M., Kaasalainen, M. H., Liu, D., Sarparanta, M. P., Airaksinen, A. J., Salonen, J., Hirvonen, J. J., & Santos, H. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.065 · Cited by 108
Yuan, H. T., Suri, C., Yancopoulos, G. D., & Woolf, A. S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081722 · Cited by 107
Drug targeting systems for inflammatory disease: One for all, all for one
Crielaard, B. J., Lammers, T., Schiffelers, R. M., & Storm, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.014 · Cited by 107
Near-Infrared Optical Imaging of Integrin α v β 3 in Human Tumor Xenografts
Wang, W., Shi, K., Wu, Q., Charnsangavej, C., Gurfinkel, M., Gelovani, J. G., Abbruzzese, J. L., Sevick-Muraca, E. M., & Li, C. (2004) · Molecular Imaging · doi:10.1162/1535350042973481 · Cited by 107
Roles of Integrins in Tumor Angiogenesis and Lymphangiogenesis
Garmy-Susini, B. H., & Varner, J. A. (2008) · Lymphatic Research and Biology · doi:10.1089/lrb.2008.1011 · Cited by 107
Yokoyama, K., Erickson, H., Ikeda, Y., & Takada, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000610200 · Cited by 106
Ocular neovascularization: a valuable model system
Campochiaro, P. A., & Hackett, S. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206773 · Cited by 106
The regulatory function of SPARC in vascular biology
Rivera, L. B., Bradshaw, A. D., & Brekken, R. A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0781-8 · Cited by 106
Antibody-based targeting of the tumor vasculature
Schliemann, C., & Neri, D. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.08.002 · Cited by 106
Cook, A. C., Tuck, A. B., McCarthy, S. M., Turner, J. G., Irby, R., Bloom, G. C., Yeatman, T. J., & Chambers, A. F. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20105 · Cited by 106
Haider, M., Zaki, K. Z., El Hamshary, M. R., Hussain, Z., Orive, G., & Ibrahim, H. O. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.008 · Cited by 106
VEGF profiling and angiogenesis in human microtissues
Kelm, J. M., Sánchez-Bustamante, C. D., Ehler, E., Hoerstrup, S. P., Djonov, V., Ittner, L. M., & Fussenegger, M. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.03.016 · Cited by 105
de Groot, F. M. H., Broxterman, H. J., Adams, H. P. H. M., van Vliet, A., TESSER, G. I., Elderkamp, Y. W., Schraa, A. J., Kok, R. J., Molema, G., Pinedo, H. M., et al. (2002) · PubMed · Cited by 105
Sheu, J., Yen, M., Kan, Y.-C., Hung, W.-C., Chang, P.-T., & Luk, H. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00057-3 · Cited by 105
Feng, X., Tonnesen, M. G., Mousa, S. A., & Clark, R. A. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/231279 · Cited by 105
Self-citationFactors Promoting Tumor Angiogenesis: Special Article
Beckner, M. E. (1999) · Cancer Investigation · doi:10.3109/07357909909032845 · Cited by 105
Zhu, Z., & Witte, L. (1999) · Investigational New Drugs · doi:10.1023/a:1006314501634 · Cited by 105
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
Rice, S. L., Roney, C. A., Daumar, P., & Lewis, J. S. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.02.002 · Cited by 105
Pilot study of vitaxin?an angiogenesis inhibitor?in patients with advanced leiomyosarcomas
Patel, S. R., Jenkins, J., Papadopolous, N., Burgess, M. A., Plager, C., Gutterman, J. U., & Benjamin, R. S. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1347::aid-cncr1456>3.0.co;2-0 · Cited by 105
An angiogenic laminin site and its antagonist bind through the αvβ3 and α5β1 integrins
Ponce, M. L., Nomizu, M., & Kleinman, H. K. (2001) · The FASEB Journal · doi:10.1096/fj.00-0736com · Cited by 104
Quarta, A., Curcio, A., Kakwere, H., & Pellegrino, T. (2012) · Nanoscale · doi:10.1039/c2nr30271c · Cited by 104
Nuclear medicine applications in molecular imaging
Blankenberg, F. G., & Strausś, H. W. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10171 · Cited by 104
Isoxazolines as Potent Antagonists of the Integrin αvβ3
Pitts, W. J., Wityak, J., Smallheer, J. M., Tobin, A. E., Jetter, J. W., Buynitsky, J. S., Harlow, P. P., Solomon, K. A., Corjay, M. H., Mousa, S. A., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900321 · Cited by 104
Taub, P. J., Marmur, J. D., Zhang, W. X., Senderoff, D. M., Nhat, P. D., Phelps, R. G., Urken, M. L., Silver, L., & Weinberg, H. (1998) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199811000-00034 · Cited by 104
Stockbauer, K. E., Magoun, L., Liu, M., Burns, E. H., Gubba, S., Renish, S., Pan, X., Bodary, S. C., Baker, E., Coburn, J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.242 · Cited by 103
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.